Logo-OHMX.bio

Immunology:
Unlocking the adaptive immune system

The adaptive immune system, with its remarkable specificity and memory, is central to our defense against pathogens and a key target for novel therapeutic interventions in areas like cancer, autoimmunity, and infectious diseases. At OHMX.bio, we provide advanced omics solutions to deeply characterize immune responses, unravel cellular diversity, and accelerate the development of precision immunotherapies. Our expertise empowers researchers and clinicians with comprehensive insights into the intricate world of immunology.
Contact our experts

Advanced omics for comprehensive immune profiling

Understanding the complexities of immune recognition and response requires high-resolution molecular analysis. OHMX.bio offers a specialized suite of services designed to meet the critical needs of immunology research:

HLA Typing

The Human Leukocyte Antigen (HLA) system plays a pivotal role in immune recognition and is critical for transplantation, vaccine development, and understanding disease susceptibility. OHMX.bio leverages advanced sequencing technologies, particularly long-read sequencing, to provide high-resolution HLA typing. This approach resolves complex HLA loci with unparalleled accuracy, crucial for precise matching in transplantation and for identifying genetic predispositions to immune-mediated diseases.
The immunopeptidome comprises the specific set of peptides displayed by HLA molecules, acting as the ultimate signals for T-cell surveillance and activation. OHMX.bio utilizes advanced proteomic workflows to directly identify and quantify these MHC-associated peptides  (both Class I and II) with high sensitivity. This direct profiling is instrumental for the discovery of tumor-specific neoantigens, the development of personalized cancer vaccines, and the precise validation of therapeutic targets.

TCR/BCR Sequencing

T-cell receptors (TCRs) and B-cell receptors (BCRs) are the unique molecular identifiers of adaptive immune cells, dictating their antigen specificity. We offer comprehensive TCR and BCR sequencing services, at both bulk and single-cell resolution, to profile immune repertoire diversity, track clonal expansions, and investigate immune responses in various disease contexts, including immuno-oncology, autoimmune disorders, and infectious diseases.

Isoform Detection & Analysis

Gene isoforms, arising from alternative splicing, significantly expand the functional diversity of the proteome and play critical roles in immune cell development, activation, and function. OHMX.bio utilizes long-read RNA sequencing to characterize full-length transcripts, enabling unambiguous identification and quantification of splice variants and fusion transcripts. This provides a more complete picture of gene expression and its impact on immune processes.

Contact our experts
OHMX.bio - Innovative omics solutions

Case studies

Case study 1: High-resolution HLA typing for large-scale cohorts

Accurate and scalable HLA typing is essential for managing large donor registries, biobanks, and for rapid assessment of acute patient samples. Traditional methods can be expensive, slow, and logistically challenging.
In a study titled “Cost-Effective and Highly Scalable Typing of HLA Classes I and II Genes of up to 96 Individuals Using Nanopore Sequencing” by Steven Verbruggen et al. (PMID: 38654300), OHMX.bio demonstrated a groundbreaking solution. This innovative approach enables HLA typing from 1 to 96 individuals simultaneously using a targeted PCR and Native Barcoding kit from Oxford Nanopore Technologies. The core point of this study was to prove that rapid, low-cost, and highly accurate HLA typing is achievable at scale, making it highly relevant for large-scale HLA typing projects and significantly accelerating research and clinical applications. The entire process, from DNA to HLA typing result, can be completed within 5.5 to 10.5 hours depending on sample numbers, with data analysis taking only 1 to 5 minutes per sample. This demonstrates OHMX.bio’s capability to deliver precise and efficient HLA typing solutions for diverse immunological studies.

Case study 2: Isoform detection reveals functional non-coding mutations in melanoma

The complexity of gene expression, particularly alternative splicing, means that mutations previously considered non-coding can have significant functional consequences. Understanding these nuances is crucial in cancer immunology, where subtle genetic changes can impact immune recognition and therapeutic response.
In a recent study (“Reannotation of cancer mutations based on expressed RNA transcripts reveals functional non-coding mutations in melanoma,” Pepe et al., 2025), researchers, including those from OHMX.bio, demonstrated the importance of integrating DNA and RNA sequencing data for accurate mutation annotation. The study revealed that a significant portion of mutations previously annotated as coding in melanoma were, in fact, non-coding due to the use of non-expressed reference transcripts. Specifically, mutations in the shared promoter region of IRF3 and BCL2L12 were found to downregulate their expression, leading to decreased TP53 levels and poorer responses to immunotherapy. This highlights how misannotated non-coding mutations in promoter regions can have functional consequences, affecting gene expression and patient response to therapy [PMID: 40359938]. This work underscores OHMX.bio’s expertise in isoform detection and its critical role in uncovering previously overlooked functional mutations, providing deeper insights into immune-related diseases like cancer.
Contact our experts

Partner with OHMX.bio for your immunology research

OHMX.bio is committed to advancing immunology research through cutting-edge omics technologies and expert bioinformatics. Our dedication to scientific excellence, precision, and rapid turnaround times ensures that you receive the highest quality data and actionable insights. Collaborate with OHMX.bio to accelerate your understanding of immune responses, identify novel therapeutic targets, and drive the development of personalized immunotherapies.
OHMX.bio_Innovative omics solutions_Tailored Personal Approach

Let’s get in touch!

Are you curious about how we can work on your -omics challenges together? Fill out the form below!
Our experts will reply within 2 working days to freely discuss your omics project.

Our publications using our cell en gene therapies

  1.  
Logo-OHMX.bio
Your partner for innovative OMICS solutions.
Linkedin Google
OHMX.bio is part of
the anacura group.

TESTING SERVICES

EXPERTISE

OHMX.bio

CONTACT

  • Belgium
    Noorwegenstraat 4
    9940 Evergem
  • Switzerland
    Phenyl - 2nd floor, Route de la Corniche 3, 1066 Epalinges
Oxford Nanopore Service Certified
logo-cir
Registered supplier logo_Scientist.com
Logo-OHMX.bio
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Cookie statement

Last updated:  19-09-2024

This cookie statement is drafted and managed by OHMX.bio NV,

hereafter referred to as “OHMX.bio”.

OHMX.bio has its headquarters at Proeftuinstraat 86, 9000 Gent, Belgium, registered with company number XXX.

For all questions and/or remarks, please contact us at the address mentioned above or at the e-mail address privacy@ohmx.bio.

USE OF COOKIES

 

OHMX.bio considers it important that you can view, listen to, read or experience our website content at any place and at any time via various media platforms. We want you to be able to use interactive features and provide services tailored to your needs. Therefore OHMX.BIO uses online techniques like cookies, scripts and similar technologies (hereafter referred to as ‘cookies’). These help us facilitate the use of the website and improve its functionality, by collecting (personal) data of our website visitors via their website usage.

 

In this cookie statement, OHMX.bio wishes to inform you what kind of cookies are used and why.

OHMX.bio can amend the cookie statement at any time. This can happen, for example, in the context of changes to its services or the applicable legislation. The amended statement will then be published on the OHMX.bio websites and will apply from the moment it is published.

 

If the use of certain cookies also involves the processing of “personal data”, the OHMX.bio Privacy Statement is also applicable.

 

WHAT ARE COOKIES?

 

A cookie is a small data file that is installed in the browser of your computer or mobile device by a website's server or application when you visit a website or use a (mobile) application.

The cookie file contains a unique code with which your browser can be recognized during the visit to the online service or during consecutive, repeated visits. They generally make the interaction between the visitor and the website or application easier and faster and help the visitor to navigate between the different parts of a website or application. They allow us to retain certain settings, such as your language choice or to optimize your user experience.

 

There are different types of cookies that can be distinguished according to their origin, function and lifespan. This is explained further in the next section.

TYPES OF COOKIES

How long are cookies stored?

Cookies can be stored on your computer or mobile device for different periods of time. Depending on the type, they (and the information they collect) are automatically deleted when you close your browser (these are the so-called “session cookies”), in other cases, these remain stored for a longer period of time and can also be used during a subsequent visit to this website (these are the so-called “permanent cookies”).

Consult the detailed information on OHMX.bio cookies (below) to know the retention periods.

Who places and manages cookies?

First-party cookies

First-party cookies are managed by OHMX.bio and are specific to the visited or used online service.

Third party cookies

Third party cookies are managed and placed by a third party. This happens during your visit or use of the website. These ensure that certain information is sent to third parties by your visit to the website.

Why cookies?

Necessary cookies

Necessary or essential cookies are necessary for the operation of the website. It is therefore advised not to disable these.

Functional cookies

These are cookies that ensure that the website functions properly. Examples of some functions performed:

- remembering your login details

- ensuring the security of your login details

- ensuring the uniformity of the layout of the website

Performance and analysis cookies

On the basis of these cookies, information is collected about the way visitors use our website. This is done with the intention to improve the content of our websites, to further adapt it to the wishes of the visitors and to increase the usability of our websites. Like for example google analytics.

Social media cookies

The website can implement so-called embedded elements of other third parties, such as YouTube, Twitter and Facebook. These are used to integrate social media into the website via plug-ins.

Other cookies

These are cookies that do not belong to one of the above categories. For example, cookies that can be used to make web analyzes themselves to optimize the website. In addition to the above-mentioned performance and analysis cookies, other web analysis cookies can be used. These will probably have to be disabled because identifiable personal data may be processed here. This is not the case with the mentioned performance analysis cookies.

OHMX.bio  uses different types of cookies.

 

Cookie Description Duration Type
cookielawinfo-checkbox-necessary This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". 1 hour Necessary
__utma This cookie is set by Google Analytics and is used to distinguish users and sessions. The cookie is created when the JavaScript library executes and there are no existing __utma cookies. The cookie is updated every time data is sent to Google Analytics. 2 years Performance
__utmc The cookie is set by Google Analytics and is deleted when the user closes the browser. The cookie is not used by ga.js. The cookie is used to enable interoperability with urchin.js which is an older version of Google analytics and used in conjunction with the __utmb cookie to determine new sessions/visits. Performance
__utmz This cookie is set by Google analytics and is used to store the traffic source or campaign through which the visitor reached your site. 5 months Performance
__utmt The cookie is set by Google Analytics and is used to throttle request rate. 10 minutes Performance
__utmb The cookie is set by Google Analytics. The cookie is used to determine new sessions/visits. The cookie is created when the JavaScript library executes and there are no existing __utma cookies. The cookie is updated every time data is sent to Google Analytics. 30 minutes Performance

 

HOW CAN YOU TURN OFF COOKIES?

 

If you choose to disable cookies, you can do so for the browser you use:

 

If you use different devices to visit this website, make sure that your cookie preferences are set on the browser of every device.

 

Please note that disabling certain cookies may result in the malfunction of related features on the website e.g. certain graphics may not show the way they are meant to, or you may not be able to use certain services.

CHANGES TO THIS COOKIE STATEMENT

OHMX.BIO may amend this Cookie Statement in accordance with certain technical, legal or commercial requirements and developments. We will inform you accordingly, taking into account the importance of the changes that have been made. You may find the date on which this Cookie Statement was last modified at the top of this Cookie Statement.